๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma

โœ Scribed by Dr. P. K. Buamah; O. F. W. James; A. W. Skillen; A. L. Harris


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
241 KB
Volume
37
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

โœฆ Synopsis


Serum alpha-fetoprotein (AFP) has been measured during chemotherapy of ten patients with hepatocellular carcinoma. Whenever the AFP concentration of a sample was lower than that of the previous sample the apparent half-life (AHL) of the protein was calculated. The biological half-life of AFP is 5 days so that values in excess of this were indicative of continuing or increased synthesis and secretion of AFP. The AHL for AFP provided a means of assessing efficacy of treatment. Increases in AHL generally predicted a rise in serum AFP and give advance warning of the need to change therapy.


๐Ÿ“œ SIMILAR VOLUMES


Bone markers in the management of patien
โœ Laurence M. Demers ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB ๐Ÿ‘ 1 views

## Background: Biochemical markers of bone remodeling have been used as surrogate markers to manage patients with metastatic bone disease. markers of the bone resorptive process, such as the bone collagen breakdown products n-telopeptide and c-telopeptide, are useful markers for monitoring the resp

Survival of patients with metastatic bre
โœ Jenny Chang; Gary M. Clark; D. Craig Allred; Syed Mohsin; Gary Chamness; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 252 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Women with metastatic breast carcinoma have a highly variable clinical course and outcome. Intrinsic genetic heterogeneity of the primary breast tumor may play a role in this variability and may explain it in part. Therefore, the authors tested the hypothesis that the cha